📄 Read our new white paper: ‘ The Case for Smarter GLP-1 Utilization: Cost, Coverage, and Clinical Outcomes '
Details
MyPhenome
Contact
📄 Read our new white paper: ‘ The Case for Smarter GLP-1 Utilization: Cost, Coverage, and Clinical Outcomes '
Platform
Evidence
Partners
Providers
Patients
Company
Our story
Meet the team
Media & press
MyPhenome
Contact
Partners
Who we partner with
Health plans
& payers:
Genetic insights for
efficient therapy
management
Optimize drug utilization
Identifying super responders who benefit most from specific therapies
Reduce drug spend
Targeted genetic testing demonstrating cost effective ways to better patient outcomes
Pharma
& CROs:
Strengthen clinical trial
outcomes with
genotyping services
Stratify patients
Identify likely responders and likely adverse effects; resulting in clearer, more successful outcomes
Generate deeper insights
Targeted genetic testing demonstrating cost effective ways to better patient outcomes
Research Institutions
& biobanks:
Synthesize evidence and validate hypotheses with industry experts
Develop studies
Identifying super responders who benefit most from specific therapies
Rapidly test
On large data sets using the Phenomix Sciences AI – enabled Platform
Partners
Interested in partnering?
Get in touch
